CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 170400-170507 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/038354e8830fe01feb621a12e8a8c467a15b6354","sourcedb":"CORD-19","sourceid":"038354e8830fe01feb621a12e8a8c467a15b6354","text":"During zanamivir treatment, a R292K NA mutation which conferred cross-resistance to all known NAIs (IC 50 :","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1068","span":{"begin":0,"end":107},"obj":"Sentence"},{"id":"T102","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1068","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T102","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T136","span":{"begin":0,"end":107},"obj":"Sentence"}],"attributes":[{"subj":"T136","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecbb93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#a193ec"}]}]}}